Dorsey & Whitney Trust CO LLC bought a new stake in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 10,410 shares of the biotechnology company’s stock, valued at approximately $39,000. A number of other large investors […]